Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.
Company profile
Ticker
ELV
Exchange
Website
CEO
Gail Boudreaux
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Former names
ANTHEM INC, Anthem, Inc., WELLPOINT INC, WELLPOINT, INC
SEC CIK
Corporate docs
Subsidiaries
Advantage Medical Group, LLC • Alianza Medicos del SurEste, LLC • Alliance Care Management, LLC • American Imaging Management, Inc. • AMERIGROUP Community Care of New Mexico, Inc. • AMERIGROUP Corporation • Amerigroup Delaware, Inc. • Amerigroup District of Columbia, Inc. • Amerigroup Insurance Company • Amerigroup Iowa, Inc. ...
IRS number
352145715
ELV stock data
Latest filings (excl ownership)
DEFA14A
Additional proxy soliciting materials
22 Apr 24
10-Q
2024 Q1
Quarterly report
18 Apr 24
8-K
Elevance Health Reports First Quarter 2024 Results
18 Apr 24
DEFA14A
Additional proxy soliciting materials
29 Mar 24
DEF 14A
Definitive proxy
29 Mar 24
8-K
Regulation FD Disclosure
4 Mar 24
S-8
Registration of securities for employees
23 Feb 24
10-K
2023 FY
Annual report
21 Feb 24
8-K
Other Events
25 Jan 24
8-K
Elevance Health Reports Results for Fourth Quarter
24 Jan 24
Transcripts
ELV
Earnings call transcript
2024 Q1
18 Apr 24
ELV
Earnings call transcript
2023 Q4
24 Jan 24
ELV
Earnings call transcript
2023 Q3
18 Oct 23
ELV
Earnings call transcript
2023 Q2
19 Jul 23
ELV
Earnings call transcript
2023 Q1
19 Apr 23
ELV
Earnings call transcript
2022 Q4
25 Jan 23
ELV
Earnings call transcript
2022 Q3
19 Oct 22
ELV
Earnings call transcript
2022 Q2
20 Jul 22
ELV
Earnings call transcript
2022 Q1
20 Apr 22
ELV
Earnings call transcript
2022 Q1
20 Apr 22
Latest ownership filings
144
Notice of proposed sale of securities
23 Apr 24
4
Charles Morgan Kendrick JR
12 Mar 24
4
Ronald W Penczek
8 Mar 24
144
Notice of proposed sale of securities
8 Mar 24
144
Notice of proposed sale of securities
6 Mar 24
4
Ronald W Penczek
5 Mar 24
4
Blair Williams Todt
5 Mar 24
4
RATNAKAR LAVU
5 Mar 24
4
Charles Morgan Kendrick JR
5 Mar 24
4
Felicia F Norwood
5 Mar 24
Financial summary
Quarter (USD) | Sep 23 | Jun 23 | Mar 23 | Dec 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Institutional ownership, Q4 2023
62.0% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1335 |
Opened positions | 182 |
Closed positions | 332 |
Increased positions | 490 |
Reduced positions | 470 |
13F shares | Current |
---|---|
Total value | 58.87 tn |
Total shares | 144.13 mm |
Total puts | 325.66 k |
Total calls | 181.49 k |
Total put/call ratio | 1.8 |
Largest owners | Shares | Value |
---|---|---|
Vanguard | 21.23 mm | $10.01 tn |
T. Rowe Price | 11.92 mm | $5.62 bn |
STT State Street | 10.41 mm | $4.91 tn |
Wellington Management | 5.91 mm | $2.79 tn |
Sanders Capital | 4.46 mm | $2.10 tn |
FMR | 3.97 mm | $1.87 tn |
Capital International Investors | 3.37 mm | $1.59 tn |
Baillie Gifford & Co | 3.09 mm | $1.46 tn |
MS Morgan Stanley | 2.90 mm | $1.37 tn |
NTRS Northern Trust | 2.33 mm | $1.10 tn |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Mar 24 | Charles Morgan Kendrick JR | Common Stock | Sell | Dispose S | No | No | 500.46 | 2,432 | 1.22 mm | 15,840 |
6 Mar 24 | Ronald W Penczek | Common Stock | Sell | Dispose S | No | No | 504.58 | 916 | 462.20 k | 1,764 |
1 Mar 24 | Ronald W Penczek | Common Stock | Grant | Acquire A | No | No | 0 | 1,046 | 0.00 | 2,680 |
1 Mar 24 | Ronald W Penczek | Common Stock | Grant | Acquire A | No | No | 0 | 226 | 0.00 | 1,634 |
1 Mar 24 | Ronald W Penczek | Common Stock | Payment of exercise | Dispose F | No | No | 499.11 | 383 | 191.16 k | 1,408 |
1 Mar 24 | Ronald W Penczek | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 499.11 | 867 | 432.73 k | 867 |
1 Mar 24 | Blair Williams Todt | Common Stock | Grant | Acquire A | No | No | 0 | 6,537 | 0.00 | 17,156 |
1 Mar 24 | Blair Williams Todt | Common Stock | Grant | Acquire A | No | No | 0 | 2,154 | 0.00 | 10,619 |
1 Mar 24 | Blair Williams Todt | Common Stock | Payment of exercise | Dispose F | No | No | 499.11 | 3,650 | 1.82 mm | 8,465 |
1 Mar 24 | Blair Williams Todt | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 499.11 | 8,312 | 4.15 mm | 8,312 |
News
Tracking Last Week's Top Performers: Are These 7 Large-Cap Stocks In Your Portfolio?
21 Apr 24
Wells Fargo Maintains Overweight on Elevance Health, Raises Price Target to $600
19 Apr 24
Elevance Health Analysts Boost Their Forecasts After Upbeat Earnings
19 Apr 24
Jefferies Maintains Buy on Elevance Health, Raises Price Target to $604
19 Apr 24
Barclays Maintains Overweight on Elevance Health, Raises Price Target to $621
19 Apr 24
Press releases
Elevance Health Reports First Quarter 2024 Results
18 Apr 24
Elevance Health and Clayton, Dubilier & Rice Sign Agreement to Launch Strategic Partnership to Advance Primary Care Delivery
15 Apr 24
Elevance Health to Hold Conference Call and Webcast to Discuss First Quarter 2024 Results on April 18, 2024
3 Apr 24
Elevance Health Announces Closing of Paragon Healthcare Acquisition
11 Mar 24
Performant Financial Corporation Announces the Appointment of Dr. Shantanu Agrawal to Its Board of Directors
6 Mar 24